Annapolis Financial Services LLC Acquires 100 Shares of Zoetis Inc. (NYSE:ZTS)

Annapolis Financial Services LLC raised its position in Zoetis Inc. (NYSE:ZTS) by 32.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 409 shares of the company’s stock after buying an additional 100 shares during the quarter. Annapolis Financial Services LLC’s holdings in Zoetis were worth $69,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Peak Financial Advisors LLC acquired a new stake in shares of Zoetis during the 4th quarter worth $2,776,000. Focus Financial Network Inc. ADV acquired a new stake in Zoetis in the fourth quarter valued at about $2,159,000. Price T Rowe Associates Inc. MD boosted its stake in Zoetis by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after buying an additional 3,244,074 shares in the last quarter. Ninety One UK Ltd boosted its stake in Zoetis by 13.1% in the fourth quarter. Ninety One UK Ltd now owns 108,293 shares of the company’s stock valued at $21,374,000 after buying an additional 12,537 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. boosted its stake in Zoetis by 10.9% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 183,564 shares of the company’s stock valued at $36,230,000 after buying an additional 17,976 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ZTS has been the subject of several research reports. The Goldman Sachs Group dropped their target price on Zoetis from $223.00 to $196.00 and set a “buy” rating for the company in a research report on Monday, May 6th. Piper Sandler reiterated an “overweight” rating and issued a $195.00 target price (down from $220.00) on shares of Zoetis in a research report on Tuesday, April 16th. HSBC dropped their target price on Zoetis from $230.00 to $225.00 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Stifel Nicolaus dropped their target price on Zoetis from $195.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Finally, Barclays lowered their price objective on Zoetis from $260.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 23rd. Eight analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $211.75.

Zoetis Trading Down 1.8 %

ZTS stock traded down $3.10 during mid-day trading on Friday, reaching $173.36. The company’s stock had a trading volume of 4,189,580 shares, compared to its average volume of 2,374,760. The company has a market cap of $79.10 billion, a price-to-earnings ratio of 33.40, a price-to-earnings-growth ratio of 2.69 and a beta of 0.88. The business’s 50 day moving average price is $168.69 and its 200 day moving average price is $178.72. The company has a current ratio of 3.33, a quick ratio of 1.94 and a debt-to-equity ratio of 1.30. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92.

Zoetis (NYSE:ZTS) last issued its earnings results on Thursday, May 2nd. The company reported $1.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.04. The business had revenue of $2.19 billion during the quarter, compared to the consensus estimate of $2.14 billion. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.31 earnings per share. On average, equities research analysts predict that Zoetis Inc. will post 5.76 EPS for the current year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 4th. Shareholders of record on Thursday, July 18th will be paid a $0.432 dividend. The ex-dividend date of this dividend is Thursday, July 18th. This represents a $1.73 dividend on an annualized basis and a yield of 1.00%. Zoetis’s dividend payout ratio (DPR) is presently 33.33%.

Insider Buying and Selling at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 923 shares of the firm’s stock in a transaction that occurred on Thursday, April 18th. The stock was sold at an average price of $151.17, for a total value of $139,529.91. Following the completion of the sale, the executive vice president now owns 14,800 shares of the company’s stock, valued at $2,237,316. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.16% of the company’s stock.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.